Atlas Trials

Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer

Clinical trial NCT01298570 · COMPLETED

Trial details

NCT number
NCT01298570
Sponsor
UNC Lineberger Comprehensive Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Colorectal Cancer Metastatic
Start date
2011-04-07
Primary completion
2016-11-15
Enrollment
181

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.